Marie-Hélène Wasmer

962 total citations
10 papers, 789 citations indexed

About

Marie-Hélène Wasmer is a scholar working on Immunology, Oncology and Surgery. According to data from OpenAlex, Marie-Hélène Wasmer has authored 10 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 5 papers in Oncology and 3 papers in Surgery. Recurrent topics in Marie-Hélène Wasmer's work include IL-33, ST2, and ILC Pathways (5 papers), Immune Cell Function and Interaction (5 papers) and Eosinophilic Esophagitis (3 papers). Marie-Hélène Wasmer is often cited by papers focused on IL-33, ST2, and ILC Pathways (5 papers), Immune Cell Function and Interaction (5 papers) and Eosinophilic Esophagitis (3 papers). Marie-Hélène Wasmer collaborates with scholars based in Switzerland, Germany and Austria. Marie-Hélène Wasmer's co-authors include Philippe Krebs, Lukas F. Mager, Tilman T. Rau, Wolfgang Doppler, Elisabeth Müller‐Holzner, Piotr Tymoszuk, Inti Zlobec, Kathy D. McCoy, Christian M. Schürch and Alexandra Adamczyk and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Cancer Research.

In The Last Decade

Marie-Hélène Wasmer

9 papers receiving 783 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marie-Hélène Wasmer Switzerland 9 554 284 204 172 55 10 789
Yoshiki Mizukami Japan 9 498 0.9× 468 1.6× 188 0.9× 101 0.6× 89 1.6× 14 784
Zhengguang Wang China 7 665 1.2× 567 2.0× 141 0.7× 81 0.5× 75 1.4× 18 935
Ganapathy Sriram United States 13 342 0.6× 185 0.7× 280 1.4× 45 0.3× 44 0.8× 19 679
Bryan C. McIntosh United States 9 223 0.4× 196 0.7× 104 0.5× 103 0.6× 70 1.3× 13 445
Meegan Howlett Australia 14 213 0.4× 282 1.0× 265 1.3× 263 1.5× 97 1.8× 24 720
Nobuyoshi Nasu Japan 10 278 0.5× 224 0.8× 222 1.1× 113 0.7× 60 1.1× 21 583
Yuka Igarashi Japan 13 256 0.5× 169 0.6× 161 0.8× 81 0.5× 42 0.8× 30 551
P. Jiménez Spain 12 355 0.6× 225 0.8× 145 0.7× 75 0.4× 34 0.6× 24 624
Sara Santagata Italy 13 262 0.5× 227 0.8× 126 0.6× 109 0.6× 60 1.1× 19 602
Rémi Fiancette United Kingdom 15 553 1.0× 138 0.5× 212 1.0× 155 0.9× 16 0.3× 27 778

Countries citing papers authored by Marie-Hélène Wasmer

Since Specialization
Citations

This map shows the geographic impact of Marie-Hélène Wasmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie-Hélène Wasmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie-Hélène Wasmer more than expected).

Fields of papers citing papers by Marie-Hélène Wasmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie-Hélène Wasmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie-Hélène Wasmer. The network helps show where Marie-Hélène Wasmer may publish in the future.

Co-authorship network of co-authors of Marie-Hélène Wasmer

This figure shows the co-authorship network connecting the top 25 collaborators of Marie-Hélène Wasmer. A scholar is included among the top collaborators of Marie-Hélène Wasmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie-Hélène Wasmer. Marie-Hélène Wasmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Adamczyk, Alexandra, Eva Pastille, Jan Kehrmann, et al.. (2021). GPR15 Facilitates Recruitment of Regulatory T Cells to Promote Colorectal Cancer. Cancer Research. 81(11). 2970–2982. 23 indexed citations
3.
Schürch, Christian M., Stefan Förster, Marie-Hélène Wasmer, et al.. (2019). Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy. Thyroid. 29(7). 979–992. 65 indexed citations
4.
Pastille, Eva, Marie-Hélène Wasmer, Alexandra Adamczyk, et al.. (2019). The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer. Mucosal Immunology. 12(4). 990–1003. 116 indexed citations
5.
Wasmer, Marie-Hélène & Philippe Krebs. (2017). The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment. Frontiers in Immunology. 7. 682–682. 67 indexed citations
6.
Mager, Lukas F., Marie-Hélène Wasmer, Tilman T. Rau, & Philippe Krebs. (2016). Cytokine-Induced Modulation of Colorectal Cancer. Frontiers in Oncology. 6. 96–96. 178 indexed citations
7.
Mager, Lukas F., Carsten Riether, Christian M. Schürch, et al.. (2015). IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms. Journal of Clinical Investigation. 125(7). 2579–2591. 73 indexed citations
8.
Mertz, Kirsten D., Lukas F. Mager, Marie-Hélène Wasmer, et al.. (2015). The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice. OncoImmunology. 5(1). e1062966–e1062966. 80 indexed citations
9.
Tymoszuk, Piotr, Hanneke Evens, Marie-Hélène Wasmer, et al.. (2014). In situ proliferation contributes to accumulation of tumor‐associated macrophages in spontaneous mammary tumors. European Journal of Immunology. 44(8). 2247–2262. 88 indexed citations
10.
Tymoszuk, Piotr, Nirmala Parajuli, Marie-Hélène Wasmer, et al.. (2013). Lapatinib and doxorubicin enhance the Stat1‐dependent antitumor immune response. European Journal of Immunology. 43(10). 2718–2729. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026